some elegant examples of catalytic CÀN formation
via CÀH activation with azides as the nitrogen source
have been reported,10À12 the direct CÀH azidation13 and
subsequent transformation of arenes still offer a distinct
challenge. Recently, by using a pyridyl directing group,
Yu et al. achieved the elegant Cu-mediated CÀH function-
alizations of 2-phenylpyridines with various nucleophilic
anion sources.14 However, the direct CÀH azidation of
2-phenylpyridine did not occur under the reported condi-
tions. Herein, the present study demonstrates the first
example of Pd-catalyzed direct CÀH azidation of arylpyr-
idines and subsequent relay of intramolecular NÀN bond
formation. (3) This transformation provides as well an
alternatively concise approach to bioactive pyrido[1,2-b]-
indazoles from readily available arylpyridines.
Scheme 1. Dehydrogenative and Atom-Incorporation Strategies
Table 1. Effects of the Reaction Parameters in the
Palladium-Catalyzed Nitrogenation Reactiona
Due to the diverse pharmacological activities, indazoles
are widely used in the pharmaceutical industry in many
drugs and drug candidates.6 Pyrido[1,2-b]indazoles are
a class of bioactive molecules containing this pharmaco-
phore, and some analogues are known to exhibit anti-
cancer activities.7 Therefore, the efficient synthesis of
pyrido[1,2-b]indazoles has attracted much attention for
a long time due to the promise of drug candidates which
contain this skeleton. The traditional strategies toward
the synthesis of pyrido[1,2-b]indazole derivatives suffer
from multistep procedures, the lack of atom economy,8
or a limited substrate scope.9 We envisioned that pyrido-
[1,2-b]indazoles could be constructed by incorporating
one N-atom into heteroarenes. Herein, we report the first
Pd-catalyzed nitrogenation reaction of 2-arylpyridines for
the synthesis of pyrido[1,2-b]indazoles (Scheme 1c).
yield of
entry
change from the “standard conditions”
2a (%)b
1
2
3
4
5
6
none
77
0
no Pd(OAc)2
no Ce(SO4)2 [with 1.0 equiv of Pd(OAc)2]
no FeCI2
0
56
61
10
Ar instead of O2
Selectfluor instead of Ce(SO4)2
dioxane instead of DMSO
CAN instead of Ce(SO4)2
DDQ instead of Ce(SO4)2
TMSN3 instead of NaN3
DMF instead of DMSO
7
15
0
8
9
0
10
0
The significance of the present finding is threefold:
(1) To the best our knowledge, this is the first example of
implanting one N-atom from an external nitrogen source
into 2-arylpyridines via CÀH activation. (2) Although
a Reaction conditions: 1a (0.3 mmol), NaN3 (2.0 equiv), Pd(OAc)2
(15 mol %), Ce(SO4)2 (2.0 equiv), FeCl2 (20 mol %), DMSO (4 mL),
stirred at 100 °C under O2 (1 atm) for 79 h. CAN = Ceric ammonium
nitrate, DDQ =2,3-Dichloro-5,6-dicyano-1,4-benzoquinone, TMSN3 =
Trimethylsilyl azide. b Isolated yields.
(6) (a) The information on the following drug and drug candidates,
please visit the PubChem website (http://pubchem.ncbi.nlm.nih.gov/),
which provides the compound structure, bioactivity, published studies,
and information regarding ongoing clinical trials, applications, and usage:
niraparib, granisetron, pazopanib, linifanib, axitinib, and GDC-0941.
(b) De Angelis, M.; Stossi, F.; Carlson, K. A.; Katzenellenbogen, B. S.;
Katzenellenbogen, K. A. J. Med. Chem. 2005, 48, 1132.
We commenced our hypothesis with 3-methoxy-2-phe-
nylpyridine 1a and sodium azide (NaN3) as a model
reaction (Table 1). After extensive screening of different
parameters, the optimum reaction conditions were deter-
mined to be Pd(OAc)2 (15 mol %), Ce(SO4)2 (2.0 equiv),
FeCl2 (20 mol %), and DMSO (4 mL), under O2 (1 atm) at
100 °C, which provided the desired nitrogenation product
2a in 77% yield (entry 1). The structure of 2a was further
ꢀ
ꢀ
ꢀ
(7) (a) Timari, G.; Soos, T.; Hajos, G.; Messmer, A.; Nacsa, J.;
ꢀ
Molnar, J. Bioorg. Med. Chem. Lett. 1996, 6, 2831. (b) Phillips, S. D.;
Castle, R. N. J. Heterocycl. Chem. 1980, 17, 1489. (c) Reddy, Y. P.;
Reddy, G. S.; Reddy, K. K. Indian J. Chem., Sect. B 1977, 15B, 1133.
(8) (a) Abramovitch, R. A.; Kalinowski, J. J. Heterocycl. Chem. 1974,
11, 857. (b) Cadogan, J. I. G.; Cameron-Wood, M.; Mackie, R. K.;
Searle, R. J. G. J. Chem. Soc. 1965, 4831. (c) Cadogan, J. I. G.; Cameron-
Wood, M. Proc. Chem. Soc., London 1962, 361. (d) Abramovitch, R. A.;
Adams, K. A. H. Can. J. Chem. 1961, 39, 2516. (e) Abramovitch, R. A.;
Ahmad, Y.; Newman, D. Tetrahedron Lett. 1961, 2, 752.
(9) Zhao, J.; Wu, C.; Li, P.; Ai, W.; Chen, H.; Wang, C.; Larock,
R. C.; Shi, F. J. Org. Chem. 2011, 76, 6837.
(10) For some recent reviews on transition-metal-catalyzed N-atom
transfer reactions of azides, see: (a) Driver, T. G. Org. Biomol. Chem.
2010, 8, 3831. (b) Cenini, S.; Gallo, E.; Caselli, A.; Ragaini, F.;
Fantauzzi, S.; Piangiolino, C. Coord. Chem. Rev. 2006, 250, 1234. (c)
Katsuki, T. Chem. Lett. 2005, 34, 1304.
(11) For some selected recent examples of intramolcular CÀH fun-
tionalization using organic azides, see: (a) Nguyen, Q.; Nguyen, T.;
Driver, T. G. J. Am. Chem. Soc. 2013, 135, 620. (b) Nguyen, Q.; Sun, K.;
Driver, T. G. J. Am. Chem. Soc. 2012, 134, 7262. (c) Stokes, B. J.; Liu, S.;
Driver, T. G. J. Am. Chem. Soc. 2011, 133, 4702. (d) Ichinose, M.;
Suematsu, H.; Yasutomi, Y.; Nishioka, Y.; Uchida, T.; Katsuki, T.
Angew. Chem., Int. Ed. 2011, 50, 9884. (e) Bonnamour, J.; Bolm, C. Org.
Lett. 2011, 13, 2012. (f) Lu, H.; Jiang, H.; Wojtas, L.; Zhang, X. P.
Angew. Chem., Int. Ed. 2010, 49, 10192. (g) Shou, W. G.; Li, J.; Guo, T.;
Lin, Z.; Jia, G. Organometallics 2009, 28, 6847.
B
Org. Lett., Vol. XX, No. XX, XXXX